799 results on '"Mejias, Asuncion"'
Search Results
2. Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies
3. Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program
4. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data
5. Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
6. Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
7. Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children
8. Fever and the Inflammatory Response
9. Contributors
10. Parainfluenza Viruses
11. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
12. Pulmonary consolidation poorly predicts bacterial infection
13. EHR-based Case Identification of Pediatric Long COVID: A Report from the RECOVER EHR Cohort
14. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
15. The interdependence between rhinovirus cycle threshold values, viral co‐detections, and clinical disease severity in children with and without comorbidities.
16. RSV Prevention Within Reach for Older Infants and Toddlers: The Role of Active Immunization.
17. Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic.
18. Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease
19. New preventive strategies for respiratory syncytial virus infection in children
20. Whole-Blood Gene Expression Profile After Hypoxic-Ischemic Encephalopathy
21. Age‐specific predictors of disease severity in children with respiratory syncytial virus infection beyond infancy and through the first 5 years of age
22. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data
23. Sex Differences in Blood Transcriptional Profiles and Clinical Phenotypes in Pediatric Patients with Eosinophilic Esophagitis
24. Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series
25. Year-Round, Routine Testing of Multiple Body Site Specimens for Human Parechovirus in Young Febrile Infants
26. Metabolomics profiling of tobacco exposure in children with cystic fibrosis
27. The journey to a respiratory syncytial virus vaccine
28. Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis
29. Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger
30. Trends in Age and Disease Severity in Children Hospitalized With RSV Infection Before and During the COVID-19 Pandemic
31. Pan-valvulitis in Children With Kawasaki Disease: A Case Report and Review of the Literature
32. Clinical and molecular characteristics of the 2022 Enterovirus-D68 outbreak among hospitalized children, Ohio, USA
33. 1621. "False-Positive" Cytomegalovirus (CMV) Screening Tests in Neonates: A Real Dilemma!
34. 1751. The Conundrum of Neonatal Herpes Simplex Virus (HSV) Disease: Co-infections do Happen!
35. 1624. SARS-CoV-2 Maternal Vaccination Induces More Efficient Placental Antibody Transfer to Newborns than SARS-CoV-2 Infection During Pregnancy
36. Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data
37. Molecular and Clinical Comparison of Enterovirus D68 Outbreaks among Hospitalized Children, Ohio, USA, 2014 and 2018
38. Mapping systemic lupus erythematosus heterogeneity at the single-cell level
39. RNA Transcriptional Biosignature Analysis for Identifying Febrile Infants With Serious Bacterial Infections in the Emergency Department
40. Infant Immune Response to Respiratory Viral Infections
41. Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.
42. Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program
43. Differential host responses within the upper respiratory tract and peripheral blood of children and adults with SARS-CoV-2 infection
44. Respiratory Syncytial Virus Seasonality : A Global Overview
45. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis
46. One Step Forward in the Road Toward a Universal Influenza Vaccine
47. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
48. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
49. Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection
50. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.